Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

ProNAi Therapeutics Inc. (DNAI), Ballard Power Systems Inc. (USA) (BLDP) & More: Major Hype Surrounding These Stocks Today

The markets are buoyant today after a report showcased a rise in US Consumer Confidence. The consumer confidence index touched its highest level in the past nine years at 104.1, up from 101.8 in August. Last night’s Presidential debate also provided a much needed boost to the market, with Hillary Clinton being declared the winner by many sources. The indices were also helped by individual stocks making strong upward moves today.

Some of the stocks impacting the markets positively today are ProNAi Therapeutics Inc. (NASDAQ:DNAI), Ballard Power Systems Inc. (USA) (NASDAQ:BLDP), Inventergy Global Inc. (NASDAQ:INVT), Array BioPharma Inc. (NASDAQ:ARRY), and EndoChoice Holdings Inc. (NYSE:GI). In this article we’ll take a look at the news driving the prices of these stocks higher and see what hedge funds think of them.

At Insider Monkey, we track more than 750 hedge funds, whose 13F filings we analyze as part of our small-cap strategy. Our research has shown that imitating a portfolio that includes the 15 most popular small-cap stocks among hedge funds can outperform the market by as much as 95 basis points per month on average (see more details here).

stock, exchange, trade, ipo, market, london, share, rate, sales, price, new, york, profit, index, broker, chart, rising, falling, street, frankfurt, wall, world, cash, points, display,


ProNAi Therapeutics Inc. (NASDAQ:DNAI) today announced that it has licensed Oncology drug PNT737 from CRT Pioneer Fund, UK. The license gives the company exclusive rights to develop and commercialize the drug. PNT737, a selective checkpoint inhibitor, is currently in Phase 1 Clinical Trails. Under the terms of the deal, ProNAi Therapeutics will pay a $7 million upfront payment, as well as up to another $2 million, subject to the fulfillment of certain conditions. Shares jumped this morning on the news but have come back to earth since, being up by 0.53% this afternoon. Among the funds that we track, nine were long ProNAi Therapeutics Inc. (NASDAQ:DNAI) at the end of June, having amassed 18.10% of its outstanding stock.

Follow Sierra Oncology Inc. (NASDAQ:SRRA)
Trade (NASDAQ:SRRA) Now!

Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) yesterday announced a new collaboration between it, Volkswagen Group, and Audi. The company has received purchase orders from Audi to accelerate certain key development activities under its ongoing Technology Solutions program with Volkswagen, with runs through early-2019. The companies’ HyMotion program is focused on the development of next-gen fuel cell stacks. The number of funds in our database long Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) stood at two on June 30, unchanged over the second quarter. Those funds held just 0.10% of Ballard’s float.

Follow Ballard Power Systems Inc (NASDAQ:BLDP)
Trade (NASDAQ:BLDP) Now!

Three more major market movers are discussed on the next page.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.